David Shaw’s BlackRock Capital Allocation Term Trust BCAT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-14,146
Closed -$214K 4563
2025
Q2
$214K Hold
14,146
﹤0.01% 4033
2025
Q1
$204K Hold
14,146
﹤0.01% 3926
2024
Q4
$214K Sell
14,146
-4,092
-22% -$65.8K ﹤0.01% 4054
2024
Q3
$300K Sell
18,238
-9,660
-35% -$158K ﹤0.01% 3975
2024
Q2
$458K Sell
27,898
-121,457
-81% -$1.95M ﹤0.01% 3673
2024
Q1
$2.49M Sell
149,355
-253,676
-63% -$3.93M ﹤0.01% 2457
2023
Q4
$6.03M Hold
403,031
0.01% 1761
2023
Q3
$5.84M Sell
403,031
-7,629
-2% -$114K 0.01% 1687
2023
Q2
$6.26M Buy
+410,660
New +$6.17M 0.01% 1698

Other funds holding BCAT

David Shaw's BCAT Position: Q3 2025 in Review

David Shaw sold out of BlackRock Capital Allocation Term Trust (BCAT) in Q3 2025, closing a stake of 14,146 shares — an estimated $214K sold.

David Shaw first reported a position in BCAT in Q2 2023 and held it in 9 quarters. The position peaked at $6.26M in Q2 2023. 94 funds tracked by Wall St. Rank hold BCAT as of Q3 2025.

  • David Shaw reported no remaining BlackRock Capital Allocation Term Trust position as of Q3 2025 after selling out during the quarter.
  • David Shaw sold 14,146 BlackRock Capital Allocation Term Trust shares in Q3 2025, an estimated $214K.
  • David Shaw first reported a position in BlackRock Capital Allocation Term Trust in Q2 2023 and held it in 9 quarters.
  • David Shaw's BlackRock Capital Allocation Term Trust position peaked at $6.26M in Q2 2023.
  • 94 funds tracked by Wall St. Rank held BlackRock Capital Allocation Term Trust as of Q3 2025.

Based on D.E. Shaw & Co's 13F filing for Q3 2025, filed 14 Nov 2025.